MRNACAUTIOUS

Return on Equity (ROE)

-36.6%

Updated 28h ago

Sector Performance

5th percentile

MRNA

-36.6%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on Equity (ROE) measures how much profit a company generates with shareholders’ money; a negative -36.6% means MRNA is losing money relative to the equity invested.

This is far below the sector median of 13.8%, placing the company in the 5th percentile among sector peers—among the worst performers. The year-over-year change is not available, but the quarter-over-quarter change shows a further decline of -12.3%, from -32.6% to -36.6%. The combination of a very poor ROE level and a worsening trend signals elevated investment risk, as the company continues to destroy shareholder value rather than generate returns. This metric directly supports the overall CAUTIOUS verdict, since it reveals persistent weakness in profitability and efficiency compared to the broader sector.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about MRNA?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are MRNA's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: CRSP (-31.2%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.